01075nas a2200277   4500000000100000008004100001260001300042653001000055653002000065653001200085653001100097653001100108653002300119653001200142100001200154700001400166700001100180700002100191245005000212856005900262300001100321490000700332050003200339520041200371022001400783       1994                            d  c1994 Sep10aAdult10aAgranulocytosis10aDapsone10aFemale10aHumans10aLeprostatic Agents10aleprosy1 aHiran S1 aPande T K1 aPani S1 aVishwanathan K A00aDapsone agranulocytosis in a leprosy patient.  uhttp://leprev.ilsl.br/pdfs/1994/v65n3/pdf/v65n3a15.pdf  a279-810 v65  aInfolep Library - available3 a<p>Dapsone-induced agranulocytosis is a rare adverse effect. There are various reports of agranulocytosis in patients treated with dapsone for malaria prophylaxis and other dermatological diseases. However, this adverse reaction in leprosy is not often encountered. We describe agranulocytosis in a young patient who was taking dapsone (100 mg) for borderline-tuberculoid leprosy in a rural environment.</p>  a0305-7518